Top Markets
#1 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +272.40%
#2 ORDI ORDI +122.29%
#3 Siren Siren +110.24%
#4 tomiNet tomiNet +77.03%
#5 pippin pippin +64.82%
#6 Neiro Neiro +54.97%
#7 Perle Perle +53.51%
#8 Axelar Axelar +46.90%
#9 Test Test +44.40%
#10 Peanut the Squirrel Peanut the Squirrel +43.15%
Coin of the day
Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin
Settings
Language
ENGLISH
Currency
USD
Theme
BriaCell Therapeutics Corp. BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCTX
Rank in Stocks #18288
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages... BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Share Price
$4.32
Market Cap
$8.14M
Change (1 day)
-6.49%
Change (1 year)
-2.88%
Country
CA
Trade BriaCell Therapeutics Corp. (BCTX)

Category

Healthcare
Revenue for BriaCell Therapeutics Corp. (BCTX)
Revenue in Apr 2026 TTM: 0
According to BriaCell Therapeutics Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for BriaCell Therapeutics Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $48.55B -
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.04B -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $14.34B -
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.08B -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $5.49B -
NL